National Jewish Health
National Jewish Health is the leading respiratory hospital in the nation. Founded in 1899 as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of patients with respiratory, cardiac, immune, and related disorders. The world-class faculty and staff at National Jewish Health are leaders in their field and provide the most up-to-date and evidence-based education on respiratory diseases, including asthma, allergy, infectious disease, COPD, COVID-19, interstitial lung disease, as well as cardiology, rheumatology, sleep, and various others. The CME Program at National Jewish Health is managed and executed by the Office of Professional Education. For access to additional educational programs please go to National Jewish Health CME.
For more information on National Jewish Health and the diseases we research and treat please go to Home.
To receive email updates on upcoming events and online CME courses, join the mailing list here.
Playback speed
10 seconds
Inhaled Treprostinil and Forced Vital Capacity in Patients With ILD and Associated Pulmonary Hypertension: A Post-hoc Analysis of the INCREASE Study
read more ↘ vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study.” during the 30-minute PH Journal Club webinar which was held on March 16, 2022.
Lancet Respir Med. 2021 Nov;9(11):1266-1274. doi: 10.1016/S2213-2600(21)00165-X. Epub 2021 Jun 29. PMID: 34214475.
View the Article Summary: https://www.nationaljewish.org/education/pro-ed/live-events/national-jewish-health-journal-clubs/pdfs/jc-article-ph-march-2022.aspx
↖ read less